Clinical Trial Update: Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

View source ↗

Summary

Novartis reports completion of a clinical trial evaluating heart failure therapy and patient outcomes in individuals with mildly reduced or preserved ejection f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: Novartis | Conditions: Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | Status: COMPLETED